Methotrexate Injection BP 25 mg (Methotrexate (Methotrexate Sodium) SOLUTION) 25 MG

Methotrexate Injection BP 25 mg is a medication used for various conditions, including certain types of cancer and autoimmune diseases. This solution is administered intra-arterially and is manufactured by Accord Healthcare Inc. in Canada.

Strength

25 MG

Pack Size

2ML

Manufacturer / TM Owner

ACCORD HEALTHCARE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methotrexate Injection BP 25 mg is commonly used in the treatment of certain cancers and autoimmune disorders. It works by interfering with the growth of certain cells in the body. This medication is often prescribed for conditions where other treatments have not been effective. It is important to follow the advice of a healthcare professional when considering the use of Methotrexate Injection BP 25 mg.

Side Effects

Common effects of Methotrexate Injection BP 25 mg may include nausea, vomiting, and fatigue. Some individuals may experience more severe side effects, such as mouth sores or changes in blood cell counts. It is important to monitor for any unusual symptoms and consult a healthcare provider if they occur.

Precautions & Warnings

Methotrexate Injection BP 25 mg should be handled with care and stored as directed. It is important to inform your healthcare provider about any allergies or medical conditions before using this medication. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

Avoid Interactions

Methotrexate Injection BP 25 mg may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other drugs that affect the immune system. Alcohol consumption should be avoided while using this medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Methotrexate Injection BP 25 mg is used for the treatment of certain types of cancer and autoimmune diseases.

Methotrexate Injection BP 25 mg is administered intra-arterially.

Common side effects may include nausea, vomiting, fatigue, and mouth sores.

Pregnant women or those planning to become pregnant should discuss the risks and benefits with their healthcare provider.

If you experience severe side effects, consult your healthcare provider immediately.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.